Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice

被引:361
作者
Li, YC
Amling, M
Pirro, AE
Priemel, M
Meuse, J
Baron, R
Delling, G
Demay, MB
机构
[1] Harvard Univ, Endocrine Unit, Massachusetts Gen Hosp, Sch Med, Boston, MA 02114 USA
[2] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA
[3] Univ Hamburg, Sch Med, Dept Bone Pathol, D-20246 Hamburg, Germany
关键词
D O I
10.1210/en.139.10.4391
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1,25-Dihydroxyvitamin D-3 plays a major role in intestinal calcium transport. To determine what phenotypic abnormalities observed in vitamin D receptor (VDR)-ablated mice are secondary to impaired intestinal calcium absorption rather than receptor deficiency, mineral ion levels were normalized by dietary means. VDR-ablated mice and control littermates were fed a diet that has been shown to prevent secondary hyperparathyroidism in vitamin D-deficient rats. This diet normalized growth and random serum ionized calcium levels in the VDR-ablated mice. The correction of ionized calcium levels prevented the development of parathyroid hyperplasia and the increases in PTH messenger RNA synthesis and in serum PTH levels. VDR-ablated animals fed this diet did not develop rickets or osteomalacia. However, alopecia was still observed in the VDR-ablated mice with normal mineral ions, suggesting that the VDR is required for normal hair growth. This study demonstrates that normalization of mineral ion homeostasis can prevent the development of hyperparathyroidism, osteomalacia, and rickets in the absence of the genomic actions of 1,25-dihydroxyvitamin D-3.
引用
收藏
页码:4391 / 4396
页数:6
相关论文
共 42 条
[1]   LONG-TERM NOCTURNAL CALCIUM INFUSIONS CAN CURE RICKETS AND PROMOTE NORMAL MINERALIZATION IN HEREDITARY RESISTANCE TO 1,25-DIHYDROXYVITAMIN-D [J].
BALSAN, S ;
GARABEDIAN, M ;
LARCHET, M ;
GORSKI, AM ;
COURNOT, G ;
TAU, C ;
BOURDEAU, A ;
SILVE, C ;
RICOUR, C .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (05) :1661-1667
[2]   VITAMIN-D, CALCIUM, AND EPIDERMAL DIFFERENTIATION [J].
BIKLE, DD ;
PILLAI, S .
ENDOCRINE REVIEWS, 1993, 14 (01) :3-19
[3]  
Brookman J J, 1986, J Bone Miner Res, V1, P529
[4]   1,25-DIHYDROXYVITAMIN-D3 SUPPRESSES PARATHYROID-HORMONE SECRETION FROM BOVINE PARATHYROID CELLS IN TISSUE-CULTURE [J].
CANTLEY, LK ;
RUSSELL, J ;
LETTIERI, D ;
SHERWOOD, LM .
ENDOCRINOLOGY, 1985, 117 (05) :2114-2119
[5]   THE VITAMIN-D STORY - A COLLABORATIVE EFFORT OF BASIC SCIENCE AND CLINICAL MEDICINE [J].
DELUCA, HF .
FASEB JOURNAL, 1988, 2 (03) :224-236
[6]   DNA-SEQUENCES IN THE RAT OSTEOCALCIN GENE THAT BIND THE 1,25-DIHYDROXYVITAMIN-D3 RECEPTOR AND CONFER RESPONSIVENESS TO 1,25-DIHYDROXYVITAMIN-D3 [J].
DEMAY, MB ;
GERARDI, JM ;
DELUCA, HF ;
KRONENBERG, HM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (01) :369-373
[7]  
DOSTAL LA, 1984, AM J PHYSIOL, V246, pG528, DOI 10.1152/ajpgi.1984.246.5.G528
[8]   Cloning of human 25-hydroxyvitamin D-1 alpha-hydroxylase and mutations causing vitamin D-dependent rickets type 1 [J].
Fu, GK ;
Lin, D ;
Zhang, MYH ;
Bikle, DD ;
Shackleton, CHL ;
Miller, WL ;
Portale, AA .
MOLECULAR ENDOCRINOLOGY, 1997, 11 (13) :1961-1970
[9]   UNDECALCIFIED PREPARATION OF BONE TISSUE - REPORT OF TECHNICAL EXPERIENCE AND DEVELOPMENT OF NEW METHODS [J].
HAHN, M ;
VOGEL, M ;
DELLING, G .
VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1991, 418 (01) :1-7
[10]   1,25-DIHYDROXYVITAMIN-D3 INHIBITS TRANSCRIPTION OF TYPE-I COLLAGEN GENES IN THE RAT OSTEO-SARCOMA CELL-LINE ROS 17/2.8 [J].
HARRISON, JR ;
PETERSEN, DN ;
LICHTLER, AC ;
MADOR, AT ;
ROWE, DW ;
KREAM, BE .
ENDOCRINOLOGY, 1989, 125 (01) :327-333